Px Pulse

S1 Ep2: Testing Long-Acting PrEP, Easier Said Than Done

Informações:

Sinopsis

Leading researcher Dr. Deborah Donnell tells us why the HIV Prevention Trials Network (HPTN) changed the design of one of two trials testing long-acting cabotegravir, as an injectable PrEP. Deb Donnell is an expert statistician, one of the great minds behind trial design and one of the best teachers we know.